As the cofounder of the Public Citizen Health Research Group, Wolfe worked for more than five decades to protect patients. But his efforts helped change medicine, too. Medscape Medical News
Author: Medscape
Panel Recommends Small Bump in 2025 Medicare Physician Pay
The influential Medicare Payment Advisory Commission also will urge Congress to establish a safety-net add-on payment for services provided to people with low incomes. Medscape Medical News
Cluster of Eye Syphilis Cases Prompts CDC Concern
A rare presentation of syphilis has experts questioning whether the bacterium has mutated. Medscape Medical News
FDA Approves Implant for Glaucoma
An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024. Medscape Medical News
Report: Kidney Disease Evident in These Eye Issues
An analysis of four new studies found that retinal and choroidal thickness in the back of the eye correlates with kidney function in patients with chronic kidney disease. Medscape Medical News
AAO 2023: Improving Patients’ QOL in Diabetic Macular Edema
Dr Sunir Garg reflects on how highlights from AAO 2023 will affect his patients with diabetic macular edema. Medscape
Lebrikizumab Gets the Nod in the EU for Atopic Dermatitis
Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States. MDedge News
Oral Therapy Shown to Preserve Retina in Stargardt Disease
A once-daily pill of modified vitamin A slowed the rate of retinal degeneration in patients with Stargardt disease, a rare genetic eye disease that can cause vision loss. Medscape Medical News
Pediatric PKP Graft Failure More Likely at Younger Ages
Performing other eye procedures during corneal transplantation in children may increase the odds of a poor outcome, according to research presented at the American Academy of Ophthalmology 2023 annual meeting. Medscape Medical News
At 2 Years, Anti-VEGF Treatment, Laser Equal for ROP: Study
For treatment of retinopathy of prematurity, intravitreal aflibercept (Eylea) and laser photocoagulation showed equivocal results at age 2 years, a European-based clinical trial found. Medscape Medical News
GLP-1s Don’t Appear to Worsen Diabetic Retinopathy
Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don’t experience a worsening of the condition, a new study found, but they still require screening and follow-up. Medscape Medical News
Novel Approach to Dry Eye Shows Promise
The experimental drug tavilermide appeared to be effective in patients with the worst symptoms of the condition, a new study finds. Medscape Medical News
Short Steroid Taper Tested With Tocilizumab for GCA
Results from a pilot study examining a shortened prednisone taper of 8 weeks’ length rather than 26 weeks suggest it may be possible to reduce patients’ duration of exposure to glucocorticoids. Medscape Medical News
Study Shows Tarcocimab May Improve Diabetic Retinopathy
A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy. Medscape Medical News
Children With Sickle Cell Disease at Risk for Vision Loss
Previously thought to be age-dependent, retinopathy affects a full third of children with sickle cell disease, a new study found. Medscape Medical News
Topical Ivermectin Study Sheds Light on Dysbiosis in Rosacea
Study findings show that ivermectin reduces the density of Demodex folliculorum in rosacea lesions, but the skin microbiome takes time to recover. Medscape Medical News
FDA Recalls Dozens More Eye Drop Products
More than 2 dozen products could cause eye infections or blindness, after bacterial contamination and unsanitary conditions were found at a manufacturing facility, the agency said. WebMD Health News
Faricimab Efficacy, Safety Hold Up in Real-World Study
A real-world study of faricimab in neovascular age-related macular degeneration showed visual and anatomical improvement in line with phase 3 trials in treatment-naive and previously treated eyes. Medscape Medical News
High-Dose Aflibercept Sustains Outcomes Over 96 Weeks
The recently approved 8-mg dose of aflibercept has shown sustained improvement in vision and anatomical markers out to 96 weeks, according to updated clinical trial results. Medscape Medical News
Eye Specialists Miss Mental Health Issues Linked to AMD
Patients with age-related macular degeneration are known to experience high rates of depression and anxiety, but clinicians often miss the problems, prompting a call for a consensus statement. Medscape Medical News